Biofire Diagnostics, Inc. manufactures, markets and sales of the film array system. Its FilmArray is an FDA-cleared multiplex PCR system that integrates sample preparation, amplification, detection and analysis. The firm has three FDA cleared panels the respiratory Panel, the blood culture identification panel, and the Gastrointestinal Panel. The company was founded by Randy Rasmussen, Carl Wittwer and Kirk Ririe in 1990 and is headquartered in Salt Lake City, UT.

IRIS International, Inc. is a manufacturer of automated in vitro diagnostic systems (IVD), sample processing products and personalized diagnostics tests for use in hospitals and laboratories worldwide. The Company’s IVD products analyze the chemistry and morphology of cells and sediments in a variety of body fluids. It is also a provider of automated urine microscopy systems, with more than 3,600 iQ microscopy analyzers shipped to date in over 50 countries. It is focused on developing, manufacturing and commercializing in vitro diagnostics instruments and consumables for urinalysis, including its flagship iQ analyzers, a family of fully-automated, image-based bench-top analyzers for urine microscopy. Its commercialized products and product pipeline comprise three main categories: morphology, sample processing and personalized medicine.

Forskarpatent i Syd AB specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. It holds a portfolio of projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets. It is involves in projects in pharmaceutical, technology, and food categories. The firm is categorized under patent agency operations. The company was founded on January 18, 1996 and is headquartered in Lund, Sweden.

Abacus Diagnostica Oy engages in rapid deoxyribonucleic acid testing technologies. It develops solutions for small-scale nucleic acid detection purposes. The firm's product GenomEra CDX system provides a tool to run DNA testing. The company was founded in 2004 and is headquartered in Turku, Finland.

Shanghai Huiyun Biotechnology Co., Ltd., established on 2010-09-30, Business scope includes biotechnology,Medical Technology,Technology development in the field of product technology,technology transfer,technical consulting,Technical Services;Development and sales of laboratory equipment;Instrumentation,Sales of office automation equipment. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Chimera Biotec offers non-regulated rapid discovery phase research as well as ultra-sensitive GLP/GCP bioanalytical support for all stages of drug development. The business describes itself as the vendor of immuno-PCR-based technology around the globe. The imperator workstation, assay development kits, and maintenance kits are among the company's products. Assay development, method validation, and bioanalysis are among the services provided.

Cepheid Inc (NASDAQ: CPHD) is an American molecular diagnostics company that develops, manufactures and markets fully integrated systems for testing in the clinical market, and for application in its original non-clinical market. The company's systems enable rapid, sophisticated molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. It was the winner of 2006 Industrial Design Excellence Awards for its product, Reagent Bead Dispenser. It won the federal contract by "MRSA Reagent Test Kits" in 2012. One of the company's customers is U.S. Food and Drug Administration (FDA). Danaher acquired Cepheid on November 4, 2016.

Leucadia Technologies, Inc., part of Danaher Corp., is a company headquartered in Encinitas, CA. The firm develops molecular diagnostics. Iris International, Inc., part of Danaher Corp. since November 2012, acquired Leucadia Technologies, Inc. on April 04, 2006 for $10.10 million.

Wuhan Jinkarui Biological Engineering Co., Ltd., established on 2013-08-19, The scope of business includes engaging in technology development in the field of biotechnology products,technical consulting,technology transfer;Technical development of biological products;Bioresearch Reagents(Does not contain dangerous goods,medicine)research and development,Production,Wholesale and retail;Scientific research equipment,Wholesale and retail of consumables;Import and export,Technology Import and Export,Agent import and export;Conference and Exhibition Services;Business Consulting(Does not include business surveys).(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Proteome Sciences Plc engages in the applied proteomics and peptidomics services and applications. It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development. The company focuses on developing proprietary protein biomarkers for neurological diseases, oncology, and organ transplant rejection. Proteome Sciences was founded on December 10, 1993 and is headquartered in Addlestone, the United Kingdom.

Shenzhen Dakwin Bioengineering Co., Ltd., established on 2011-12-15, Business scope includes general business items:R&D and sales of experimental reagents and instruments;Lymphocyte Separation Medium,Compounding and aliquoting of serum-free medium;Biotechnology information consulting and technical services;Import and export of goods or technology;Domestic Trade(law,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council).R&D and application of cell technology;Development of Human Gene Diagnosis and Therapy Technology;Medical Research and Experimental Development;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software sales;Sales of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Production of Class I Medical Devices;Production of Class II Medical Devices;Sales of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

SeraCare Life Sciences, Inc. (SeraCare) serves the global life sciences industry by providing products and services to facilitate the discovery, development and production of human and animal diagnostics and therapeutics. The Company's portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, bio banking and contract research services. It operates two segments: Diagnostic and Biopharmaceutical Products, and BioServices. The Diagnostic & Biopharmaceutical Products segment includes two types of products: controls and panels. The Bio Services segment includes bio banking, sample processing and testing services for research and clinical trials, and contract research services in molecular biology, virology, immunology and biochemistry.

Hangzhou Qianyuan Aibeiya Testing Technology Co., Ltd., established on 2009-02-11, Business scope includes technology development,Technical Services,Achievement transfer:Internal Exposure Detection Technology of Environmental Pollutants,genetic testing technology,plant,Extraction technology of intermediate components of traditional Chinese medicine,New Drugs and Nutraceuticals;technology development,Technical Services,technical consulting:DNALong-term storage technology at room temperature and related products;Serve:Educational information consultation(Excluding teaching activities and study abroad agencies),Business Management Consulting,e-commerce technology,nutrition counseling,Health Management and Consulting(Except those involving medical license),The second type of value-added telecommunications services;Production:experimental reagent,Test paper for internal exposure of environmental pollutants;Sales:Pre-packaged food,Healthy food,medical instruments(one type),experimental reagent,Test paper for internal exposure of environmental pollutants(Removal of hazardous chemicals and precursor chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jiangsu Chutian Biotechnology Co., Ltd., established on 2008-10-28, Business scope includes technical development of biomedical products,technical consulting,technology transfer,Technical Services;Bioresearch Reagents(Except for items involving medical device business licenses)Import and export of biological scientific research equipment and domestic wholesale business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Iris Molecular Diagnostics, Inc. operates as a bio-technology company. The company was founded on April 18, 2006 and is headquartered in Chatsworth. CA.

Jiangsu Academy of Agricultural Sciences is a Chinese private company located in Nanjing, with subsidiaries in China, that engages in agriculture research and development.

PaxGenBio is engaged in manufacturing and markets a portfolio of IVD products targeting infectious diseases and cancers.

Hangzhou Enshi Jiyin Technology Development Co. Ltd., part of Shanxi C&Y Pharmaceutical Group Co., Ltd., is a Chinese company located in Hangzhou. The firm engages in bio-technology development. Xue Min Zuo has been the CEO since 2014. Shanxi C&Y Pharmaceutical Group Co., Ltd. acquired Hangzhou Enshi Jiyin Technology Development Co. Ltd. on December 26, 2014 for $16.29 million.

Shanghai Jingxiang Biotechnology Co., Ltd., established on 2017-03-02, The scope of business includes engaging in biotechnology,Medical Technology,medical technology,Technology development in the field of food testing technology,Technical Services,technical consulting,technology transfer,chemical reagent(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Instrumentation,Laboratory Equipment Wholesale,retail,Engaged in the import and export of goods and technology,Class I medical device manufacturing,processing,Medical device management(See license for specific items). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Uniogen is a biotech company that specializes in rapid GenomEra PCR tests, cancer diagnostics, and Upcon labeling technology.